Medical Care
Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Research Report 2025
- Jul 08, 25
- ID: 347319
- Pages: 87
- Figures: 81
- Views: 9
The global market for AI to Novel Coronavirus (COVID-19) and Epidemic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.66%, including software, hardware and services.
This report aims to provide a comprehensive presentation of the global market for AI to Novel Coronavirus (COVID-19) and Epidemic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI to Novel Coronavirus (COVID-19) and Epidemic.
The AI to Novel Coronavirus (COVID-19) and Epidemic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI to Novel Coronavirus (COVID-19) and Epidemic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI to Novel Coronavirus (COVID-19) and Epidemic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Google
Alibaba
Artificial Intelligence in Medical Epidemiology
BlueDot
Beijing Infervision Technology Co., Ltd.
BenevolentAI
SenseTime
Insilico Medicine
DEARGEN
Iktos
SRI Biosciences
Segment by Type
AI Tracking
AI Predict
AI Recognition
Other
Segment by Application
Medical
Public Emergency
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI to Novel Coronavirus (COVID-19) and Epidemic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.66%, including software, hardware and services.
This report aims to provide a comprehensive presentation of the global market for AI to Novel Coronavirus (COVID-19) and Epidemic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI to Novel Coronavirus (COVID-19) and Epidemic.
The AI to Novel Coronavirus (COVID-19) and Epidemic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI to Novel Coronavirus (COVID-19) and Epidemic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI to Novel Coronavirus (COVID-19) and Epidemic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alibaba
Artificial Intelligence in Medical Epidemiology
BlueDot
Beijing Infervision Technology Co., Ltd.
BenevolentAI
SenseTime
Insilico Medicine
DEARGEN
Iktos
SRI Biosciences
Segment by Type
AI Tracking
AI Predict
AI Recognition
Other
Segment by Application
Medical
Public Emergency
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of AI to Novel Coronavirus (COVID-19) and Epidemic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 AI Tracking
1.2.3 AI Predict
1.2.4 AI Recognition
1.2.5 Other
1.3 Market by Application
1.3.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical
1.3.3 Public Emergency
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Perspective (2020-2031)
2.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Growth Trends by Region
2.2.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI to Novel Coronavirus (COVID-19) and Epidemic Historic Market Size by Region (2020-2025)
2.2.3 AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Region (2026-2031)
2.3 AI to Novel Coronavirus (COVID-19) and Epidemic Market Dynamics
2.3.1 AI to Novel Coronavirus (COVID-19) and Epidemic Industry Trends
2.3.2 AI to Novel Coronavirus (COVID-19) and Epidemic Market Drivers
2.3.3 AI to Novel Coronavirus (COVID-19) and Epidemic Market Challenges
2.3.4 AI to Novel Coronavirus (COVID-19) and Epidemic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI to Novel Coronavirus (COVID-19) and Epidemic Players by Revenue
3.1.1 Global Top AI to Novel Coronavirus (COVID-19) and Epidemic Players by Revenue (2020-2025)
3.1.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Players (2020-2025)
3.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI to Novel Coronavirus (COVID-19) and Epidemic Revenue
3.4 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Concentration Ratio
3.4.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI to Novel Coronavirus (COVID-19) and Epidemic Revenue in 2024
3.5 Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic Head office and Area Served
3.6 Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic, Product and Application
3.7 Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI to Novel Coronavirus (COVID-19) and Epidemic Breakdown Data by Type
4.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Historic Market Size by Type (2020-2025)
4.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Type (2026-2031)
5 AI to Novel Coronavirus (COVID-19) and Epidemic Breakdown Data by Application
5.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Historic Market Size by Application (2020-2025)
5.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (2020-2031)
6.2 North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025)
6.4 North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (2020-2031)
7.2 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025)
7.4 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (2020-2031)
8.2 Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (2020-2025)
8.4 Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (2020-2031)
9.2 Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025)
9.4 Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (2020-2031)
10.2 Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025)
10.4 Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Google
11.1.1 Google Company Details
11.1.2 Google Business Overview
11.1.3 Google AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.1.4 Google Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.1.5 Google Recent Development
11.2 Alibaba
11.2.1 Alibaba Company Details
11.2.2 Alibaba Business Overview
11.2.3 Alibaba AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.2.4 Alibaba Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.2.5 Alibaba Recent Development
11.3 Artificial Intelligence in Medical Epidemiology
11.3.1 Artificial Intelligence in Medical Epidemiology Company Details
11.3.2 Artificial Intelligence in Medical Epidemiology Business Overview
11.3.3 Artificial Intelligence in Medical Epidemiology AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.3.4 Artificial Intelligence in Medical Epidemiology Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.3.5 Artificial Intelligence in Medical Epidemiology Recent Development
11.4 BlueDot
11.4.1 BlueDot Company Details
11.4.2 BlueDot Business Overview
11.4.3 BlueDot AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.4.4 BlueDot Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.4.5 BlueDot Recent Development
11.5 Beijing Infervision Technology Co., Ltd.
11.5.1 Beijing Infervision Technology Co., Ltd. Company Details
11.5.2 Beijing Infervision Technology Co., Ltd. Business Overview
11.5.3 Beijing Infervision Technology Co., Ltd. AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.5.4 Beijing Infervision Technology Co., Ltd. Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.5.5 Beijing Infervision Technology Co., Ltd. Recent Development
11.6 BenevolentAI
11.6.1 BenevolentAI Company Details
11.6.2 BenevolentAI Business Overview
11.6.3 BenevolentAI AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.6.4 BenevolentAI Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.6.5 BenevolentAI Recent Development
11.7 SenseTime
11.7.1 SenseTime Company Details
11.7.2 SenseTime Business Overview
11.7.3 SenseTime AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.7.4 SenseTime Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.7.5 SenseTime Recent Development
11.8 Insilico Medicine
11.8.1 Insilico Medicine Company Details
11.8.2 Insilico Medicine Business Overview
11.8.3 Insilico Medicine AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.8.4 Insilico Medicine Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.8.5 Insilico Medicine Recent Development
11.9 DEARGEN
11.9.1 DEARGEN Company Details
11.9.2 DEARGEN Business Overview
11.9.3 DEARGEN AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.9.4 DEARGEN Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.9.5 DEARGEN Recent Development
11.10 Iktos
11.10.1 Iktos Company Details
11.10.2 Iktos Business Overview
11.10.3 Iktos AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.10.4 Iktos Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.10.5 Iktos Recent Development
11.11 SRI Biosciences
11.11.1 SRI Biosciences Company Details
11.11.2 SRI Biosciences Business Overview
11.11.3 SRI Biosciences AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.11.4 SRI Biosciences Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.11.5 SRI Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 AI Tracking
1.2.3 AI Predict
1.2.4 AI Recognition
1.2.5 Other
1.3 Market by Application
1.3.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical
1.3.3 Public Emergency
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Perspective (2020-2031)
2.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Growth Trends by Region
2.2.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI to Novel Coronavirus (COVID-19) and Epidemic Historic Market Size by Region (2020-2025)
2.2.3 AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Region (2026-2031)
2.3 AI to Novel Coronavirus (COVID-19) and Epidemic Market Dynamics
2.3.1 AI to Novel Coronavirus (COVID-19) and Epidemic Industry Trends
2.3.2 AI to Novel Coronavirus (COVID-19) and Epidemic Market Drivers
2.3.3 AI to Novel Coronavirus (COVID-19) and Epidemic Market Challenges
2.3.4 AI to Novel Coronavirus (COVID-19) and Epidemic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI to Novel Coronavirus (COVID-19) and Epidemic Players by Revenue
3.1.1 Global Top AI to Novel Coronavirus (COVID-19) and Epidemic Players by Revenue (2020-2025)
3.1.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Players (2020-2025)
3.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI to Novel Coronavirus (COVID-19) and Epidemic Revenue
3.4 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Concentration Ratio
3.4.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI to Novel Coronavirus (COVID-19) and Epidemic Revenue in 2024
3.5 Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic Head office and Area Served
3.6 Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic, Product and Application
3.7 Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI to Novel Coronavirus (COVID-19) and Epidemic Breakdown Data by Type
4.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Historic Market Size by Type (2020-2025)
4.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Type (2026-2031)
5 AI to Novel Coronavirus (COVID-19) and Epidemic Breakdown Data by Application
5.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Historic Market Size by Application (2020-2025)
5.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (2020-2031)
6.2 North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025)
6.4 North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (2020-2031)
7.2 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025)
7.4 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (2020-2031)
8.2 Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (2020-2025)
8.4 Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (2020-2031)
9.2 Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025)
9.4 Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (2020-2031)
10.2 Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025)
10.4 Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Google
11.1.1 Google Company Details
11.1.2 Google Business Overview
11.1.3 Google AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.1.4 Google Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.1.5 Google Recent Development
11.2 Alibaba
11.2.1 Alibaba Company Details
11.2.2 Alibaba Business Overview
11.2.3 Alibaba AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.2.4 Alibaba Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.2.5 Alibaba Recent Development
11.3 Artificial Intelligence in Medical Epidemiology
11.3.1 Artificial Intelligence in Medical Epidemiology Company Details
11.3.2 Artificial Intelligence in Medical Epidemiology Business Overview
11.3.3 Artificial Intelligence in Medical Epidemiology AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.3.4 Artificial Intelligence in Medical Epidemiology Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.3.5 Artificial Intelligence in Medical Epidemiology Recent Development
11.4 BlueDot
11.4.1 BlueDot Company Details
11.4.2 BlueDot Business Overview
11.4.3 BlueDot AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.4.4 BlueDot Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.4.5 BlueDot Recent Development
11.5 Beijing Infervision Technology Co., Ltd.
11.5.1 Beijing Infervision Technology Co., Ltd. Company Details
11.5.2 Beijing Infervision Technology Co., Ltd. Business Overview
11.5.3 Beijing Infervision Technology Co., Ltd. AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.5.4 Beijing Infervision Technology Co., Ltd. Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.5.5 Beijing Infervision Technology Co., Ltd. Recent Development
11.6 BenevolentAI
11.6.1 BenevolentAI Company Details
11.6.2 BenevolentAI Business Overview
11.6.3 BenevolentAI AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.6.4 BenevolentAI Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.6.5 BenevolentAI Recent Development
11.7 SenseTime
11.7.1 SenseTime Company Details
11.7.2 SenseTime Business Overview
11.7.3 SenseTime AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.7.4 SenseTime Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.7.5 SenseTime Recent Development
11.8 Insilico Medicine
11.8.1 Insilico Medicine Company Details
11.8.2 Insilico Medicine Business Overview
11.8.3 Insilico Medicine AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.8.4 Insilico Medicine Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.8.5 Insilico Medicine Recent Development
11.9 DEARGEN
11.9.1 DEARGEN Company Details
11.9.2 DEARGEN Business Overview
11.9.3 DEARGEN AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.9.4 DEARGEN Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.9.5 DEARGEN Recent Development
11.10 Iktos
11.10.1 Iktos Company Details
11.10.2 Iktos Business Overview
11.10.3 Iktos AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.10.4 Iktos Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.10.5 Iktos Recent Development
11.11 SRI Biosciences
11.11.1 SRI Biosciences Company Details
11.11.2 SRI Biosciences Business Overview
11.11.3 SRI Biosciences AI to Novel Coronavirus (COVID-19) and Epidemic Introduction
11.11.4 SRI Biosciences Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
11.11.5 SRI Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of AI Tracking
Table 3. Key Players of AI Predict
Table 4. Key Players of AI Recognition
Table 5. Key Players of Other
Table 6. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Region (2020-2025)
Table 10. Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Region (2026-2031)
Table 12. AI to Novel Coronavirus (COVID-19) and Epidemic Market Trends
Table 13. AI to Novel Coronavirus (COVID-19) and Epidemic Market Drivers
Table 14. AI to Novel Coronavirus (COVID-19) and Epidemic Market Challenges
Table 15. AI to Novel Coronavirus (COVID-19) and Epidemic Market Restraints
Table 16. Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Players (2020-2025)
Table 18. Global Top AI to Novel Coronavirus (COVID-19) and Epidemic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic as of 2024)
Table 19. Ranking of Global Top AI to Novel Coronavirus (COVID-19) and Epidemic Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by AI to Novel Coronavirus (COVID-19) and Epidemic Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic, Headquarters and Area Served
Table 22. Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic, Product and Application
Table 23. Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Type (2020-2025)
Table 27. Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Type (2026-2031)
Table 29. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Application (2020-2025)
Table 31. Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Application (2026-2031)
Table 33. North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031) & (US$ Million)
Table 48. Google Company Details
Table 49. Google Business Overview
Table 50. Google AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 51. Google Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 52. Google Recent Development
Table 53. Alibaba Company Details
Table 54. Alibaba Business Overview
Table 55. Alibaba AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 56. Alibaba Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 57. Alibaba Recent Development
Table 58. Artificial Intelligence in Medical Epidemiology Company Details
Table 59. Artificial Intelligence in Medical Epidemiology Business Overview
Table 60. Artificial Intelligence in Medical Epidemiology AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 61. Artificial Intelligence in Medical Epidemiology Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 62. Artificial Intelligence in Medical Epidemiology Recent Development
Table 63. BlueDot Company Details
Table 64. BlueDot Business Overview
Table 65. BlueDot AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 66. BlueDot Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 67. BlueDot Recent Development
Table 68. Beijing Infervision Technology Co., Ltd. Company Details
Table 69. Beijing Infervision Technology Co., Ltd. Business Overview
Table 70. Beijing Infervision Technology Co., Ltd. AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 71. Beijing Infervision Technology Co., Ltd. Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 72. Beijing Infervision Technology Co., Ltd. Recent Development
Table 73. BenevolentAI Company Details
Table 74. BenevolentAI Business Overview
Table 75. BenevolentAI AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 76. BenevolentAI Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 77. BenevolentAI Recent Development
Table 78. SenseTime Company Details
Table 79. SenseTime Business Overview
Table 80. SenseTime AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 81. SenseTime Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 82. SenseTime Recent Development
Table 83. Insilico Medicine Company Details
Table 84. Insilico Medicine Business Overview
Table 85. Insilico Medicine AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 86. Insilico Medicine Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 87. Insilico Medicine Recent Development
Table 88. DEARGEN Company Details
Table 89. DEARGEN Business Overview
Table 90. DEARGEN AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 91. DEARGEN Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 92. DEARGEN Recent Development
Table 93. Iktos Company Details
Table 94. Iktos Business Overview
Table 95. Iktos AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 96. Iktos Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 97. Iktos Recent Development
Table 98. SRI Biosciences Company Details
Table 99. SRI Biosciences Business Overview
Table 100. SRI Biosciences AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 101. SRI Biosciences Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 102. SRI Biosciences Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. AI to Novel Coronavirus (COVID-19) and Epidemic Picture
Figure 2. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Type: 2024 VS 2031
Figure 4. AI Tracking Features
Figure 5. AI Predict Features
Figure 6. AI Recognition Features
Figure 7. Other Features
Figure 8. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Application: 2024 VS 2031
Figure 10. Medical Case Studies
Figure 11. Public Emergency Case Studies
Figure 12. Other Case Studies
Figure 13. AI to Novel Coronavirus (COVID-19) and Epidemic Report Years Considered
Figure 14. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Region: 2024 VS 2031
Figure 17. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Players in 2024
Figure 18. Global Top AI to Novel Coronavirus (COVID-19) and Epidemic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by AI to Novel Coronavirus (COVID-19) and Epidemic Revenue in 2024
Figure 20. North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Country (2020-2031)
Figure 22. United States AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Country (2020-2031)
Figure 26. Germany AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Region (2020-2031)
Figure 34. China AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Country (2020-2031)
Figure 42. Mexico AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Country (2020-2031)
Figure 46. Turkey AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Google Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 50. Alibaba Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 51. Artificial Intelligence in Medical Epidemiology Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 52. BlueDot Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 53. Beijing Infervision Technology Co., Ltd. Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 54. BenevolentAI Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 55. SenseTime Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 56. Insilico Medicine Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 57. DEARGEN Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 58. Iktos Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 59. SRI Biosciences Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of AI Tracking
Table 3. Key Players of AI Predict
Table 4. Key Players of AI Recognition
Table 5. Key Players of Other
Table 6. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Region (2020-2025)
Table 10. Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Region (2026-2031)
Table 12. AI to Novel Coronavirus (COVID-19) and Epidemic Market Trends
Table 13. AI to Novel Coronavirus (COVID-19) and Epidemic Market Drivers
Table 14. AI to Novel Coronavirus (COVID-19) and Epidemic Market Challenges
Table 15. AI to Novel Coronavirus (COVID-19) and Epidemic Market Restraints
Table 16. Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Players (2020-2025)
Table 18. Global Top AI to Novel Coronavirus (COVID-19) and Epidemic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic as of 2024)
Table 19. Ranking of Global Top AI to Novel Coronavirus (COVID-19) and Epidemic Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by AI to Novel Coronavirus (COVID-19) and Epidemic Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic, Headquarters and Area Served
Table 22. Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic, Product and Application
Table 23. Global Key Players of AI to Novel Coronavirus (COVID-19) and Epidemic, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Type (2020-2025)
Table 27. Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Type (2026-2031)
Table 29. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Application (2020-2025)
Table 31. Global AI to Novel Coronavirus (COVID-19) and Epidemic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Application (2026-2031)
Table 33. North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country (2026-2031) & (US$ Million)
Table 48. Google Company Details
Table 49. Google Business Overview
Table 50. Google AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 51. Google Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 52. Google Recent Development
Table 53. Alibaba Company Details
Table 54. Alibaba Business Overview
Table 55. Alibaba AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 56. Alibaba Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 57. Alibaba Recent Development
Table 58. Artificial Intelligence in Medical Epidemiology Company Details
Table 59. Artificial Intelligence in Medical Epidemiology Business Overview
Table 60. Artificial Intelligence in Medical Epidemiology AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 61. Artificial Intelligence in Medical Epidemiology Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 62. Artificial Intelligence in Medical Epidemiology Recent Development
Table 63. BlueDot Company Details
Table 64. BlueDot Business Overview
Table 65. BlueDot AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 66. BlueDot Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 67. BlueDot Recent Development
Table 68. Beijing Infervision Technology Co., Ltd. Company Details
Table 69. Beijing Infervision Technology Co., Ltd. Business Overview
Table 70. Beijing Infervision Technology Co., Ltd. AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 71. Beijing Infervision Technology Co., Ltd. Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 72. Beijing Infervision Technology Co., Ltd. Recent Development
Table 73. BenevolentAI Company Details
Table 74. BenevolentAI Business Overview
Table 75. BenevolentAI AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 76. BenevolentAI Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 77. BenevolentAI Recent Development
Table 78. SenseTime Company Details
Table 79. SenseTime Business Overview
Table 80. SenseTime AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 81. SenseTime Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 82. SenseTime Recent Development
Table 83. Insilico Medicine Company Details
Table 84. Insilico Medicine Business Overview
Table 85. Insilico Medicine AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 86. Insilico Medicine Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 87. Insilico Medicine Recent Development
Table 88. DEARGEN Company Details
Table 89. DEARGEN Business Overview
Table 90. DEARGEN AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 91. DEARGEN Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 92. DEARGEN Recent Development
Table 93. Iktos Company Details
Table 94. Iktos Business Overview
Table 95. Iktos AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 96. Iktos Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 97. Iktos Recent Development
Table 98. SRI Biosciences Company Details
Table 99. SRI Biosciences Business Overview
Table 100. SRI Biosciences AI to Novel Coronavirus (COVID-19) and Epidemic Product
Table 101. SRI Biosciences Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025) & (US$ Million)
Table 102. SRI Biosciences Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. AI to Novel Coronavirus (COVID-19) and Epidemic Picture
Figure 2. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Type: 2024 VS 2031
Figure 4. AI Tracking Features
Figure 5. AI Predict Features
Figure 6. AI Recognition Features
Figure 7. Other Features
Figure 8. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Application: 2024 VS 2031
Figure 10. Medical Case Studies
Figure 11. Public Emergency Case Studies
Figure 12. Other Case Studies
Figure 13. AI to Novel Coronavirus (COVID-19) and Epidemic Report Years Considered
Figure 14. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Region: 2024 VS 2031
Figure 17. Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Players in 2024
Figure 18. Global Top AI to Novel Coronavirus (COVID-19) and Epidemic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI to Novel Coronavirus (COVID-19) and Epidemic as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by AI to Novel Coronavirus (COVID-19) and Epidemic Revenue in 2024
Figure 20. North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Country (2020-2031)
Figure 22. United States AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Country (2020-2031)
Figure 26. Germany AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Region (2020-2031)
Figure 34. China AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Country (2020-2031)
Figure 42. Mexico AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Country (2020-2031)
Figure 46. Turkey AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE AI to Novel Coronavirus (COVID-19) and Epidemic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Google Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 50. Alibaba Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 51. Artificial Intelligence in Medical Epidemiology Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 52. BlueDot Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 53. Beijing Infervision Technology Co., Ltd. Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 54. BenevolentAI Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 55. SenseTime Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 56. Insilico Medicine Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 57. DEARGEN Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 58. Iktos Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 59. SRI Biosciences Revenue Growth Rate in AI to Novel Coronavirus (COVID-19) and Epidemic Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232